Delivery Order SPE2DB24D1006-SPE2DB25FCEWK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,034.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 10, 2025, with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,534.20 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,767.04 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a ceiling value of $1,397.48. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to complete by May 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,033.47 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with performance scheduled for completion by August 18, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $3,049.07 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation, with performance to be executed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,226.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with an award date of August 25, 2025 and ultimate completion date of August 26, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lantus SoloStar insulin 100 unit/mL in 3 mL pens. This non-set-aside, competitively awarded contract carries a ceiling value of $2,171.76 with firm fixed pricing and an ultimate completion date of August 4, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,400.29 on June 2, 2025, for the supply of Lantus SoloStar 100 Unit/ml 3ml insulin pens. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEWKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens, valued at $1,415.40. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under DLA's existing contract vehicle. The order is scheduled for completion by July 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide. The delivery order exemplifies the company's role in fulfilling routine pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through the flexible IDC structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/14/25 |